Nuñez-Mora Carlos, García-Mediero Jose M, Cabrera-Castillo Pedro M
Servicio de Urología, Hospital Oncológico MD Anderson International España, Madrid, Spain.
J Endourol. 2009 Aug;23(8):1301-5. doi: 10.1089/end.2009.0019.
To analyze the surgical, functional, and oncological results of radical laparoscopic salvage prostatectomy in local postradiotherapy recurrence.
Between May 2005 and April 2007, we treated nine patients with radical laparoscopic salvage prostatectomy. Five patients had received prior treatment with brachytherapy and the other four with external radiotherapy. The average age of the patients was 59.3 years (range 51-68). The average preoperative prostate-specific antigen was 9.1 ng/mL (range 2.6-30). The average follow-up period was 26.8 months (range 15-39).
The average duration of surgery was 170 minutes (from 120 to 240). There was no need to resort to open surgery or transfusions. There were no cases of rectal injuries. Four cases were pT2c, 1 pT3a, 3 pT3b, and 1 pT4a. The Gleason score was 7 in three cases, 8 in two cases, and 9 in another four. Two patients had nodal metastasis. Postoperative prostate-specific antigen was undetectable in seven of the nine patients. Two patients experienced biochemical recurrence 16 and 13 months after the surgery. After a minimum follow-up period of 15 months, they were free from recurrence. There were no cases of urethrovesical anastomotic stenosis. Three patients manifested severe incontinence (more than two diapers per day), which was corrected in two cases by implanting an artificial sphincter. The other six patients required 0 to 1 pads/day. Before the surgery, only one of the five potential patients maintained his erectile function.
Radical laparoscopic salvage prostatectomy is a complex technique that seems to allow attaining high and long-lasting rates of biochemical remission in patients with local postradiotherapy recurrence. Although there is less morbidity in our series in comparison with the anastomotic stenosis and rectal injuries rate published in radical retropubic salvage prostatectomy, more extensive comparative studies are required to confirm this fact.
分析根治性腹腔镜挽救性前列腺切除术治疗局部放疗后复发的手术、功能及肿瘤学效果。
2005年5月至2007年4月,我们对9例患者实施了根治性腹腔镜挽救性前列腺切除术。5例患者先前接受了近距离放疗,另外4例接受了体外放疗。患者的平均年龄为59.3岁(范围51 - 68岁)。术前平均前列腺特异性抗原为9.1 ng/mL(范围2.6 - 30)。平均随访期为26.8个月(范围15 - 39个月)。
平均手术时长为170分钟(120至240分钟)。无需转为开放手术或输血。无直肠损伤病例。4例为pT2c,1例为pT3a,3例为pT3b,1例为pT4a。Gleason评分3例为7分,2例为8分,另外4例为9分。2例患者有淋巴结转移。9例患者中有7例术后前列腺特异性抗原检测不到。2例患者在术后16个月和13个月出现生化复发。经过至少15个月的随访,他们无复发。无尿道膀胱吻合口狭窄病例。3例患者表现为严重尿失禁(每天使用超过两片尿片),其中2例通过植入人工括约肌得到纠正。其他6例患者每天需要0至1片尿垫。术前,5例有勃起功能保留可能的患者中只有1例维持了勃起功能。
根治性腹腔镜挽救性前列腺切除术是一项复杂技术,似乎能使局部放疗后复发患者获得较高且持久的生化缓解率。尽管与耻骨后根治性挽救性前列腺切除术报道的吻合口狭窄和直肠损伤率相比,我们系列研究中的发病率较低,但仍需要更广泛的对照研究来证实这一事实。